The biological utilization rate of phospholipids is high

Choline is an essential nutrient participating in liver lipid metabolism, neurotransmitter synthesis and cell membrane structure maintenance. Human bodies cannot synthesize sufficient choline independently, so exogenous dietary intake is indispensable. Free-form choline salts are widely used in nutritional fortification products, yet they face limitations such as fast gastrointestinal transit speed, partial degradation in intestinal lumen and relatively low utilization efficiency. Phospholipid‑bound choline presents distinct advantages in absorption and metabolic delivery. Existing nutritional research confirms that choline embedded within phospholipid molecular structure demonstrates higher bioavailability compared with common free choline sources, bringing more stable and sustained choline supply for human physiological demands.

The essential difference lies in the existing binding state of choline molecules. For free choline chloride or other choline salts, choline exists as dissociated cation after dissolution in gastrointestinal fluid. A large fraction of free choline will be metabolized by intestinal microbiota before entering systemic circulation, generating trimethylamine and other by-products, which not only reduces the amount of choline reaching target organs, but also may trigger body odor related metabolic responses. In phospholipid molecules, choline connects to the glycerol backbone via phosphodiester bonds, forming an integrated phospholipid complex instead of dissociating into free choline ions under gastrointestinal conditions. This covalent-binding structure protects choline molecules from premature degradation by gut bacteria during digestion.

In the digestive tract, phospholipids undergo step-wise hydrolysis catalyzed by pancreatic phospholipase and intestinal mucosal enzymes. The enzymatic reaction mainly takes place on the brush border of small intestinal epithelium. Choline is released gradually along with the breakdown of phospholipid skeleton right near absorption sites. Such localized release mode cuts down the exposure time of choline within the intestinal cavity, greatly lowering the chance of bacterial decomposition. Part of intact small‑molecular phospholipid-choline complexes can also be taken up through epithelial cell membrane transport pathways directly, further improving overall absorption efficiency, which cannot be achieved by free choline that is mostly absorbed via simple diffusion.

After intestinal absorption, phospholipid-derived choline enters the circulatory system in the form of assembled lipoprotein particles. It is transported to liver, brain and other target tissues together with lipid carriers. Free choline absorbed into blood tends to be rapidly cleared and metabolized, resulting in sharp short-term blood concentration peaks followed by fast decline. By contrast, phospholipid-bound choline supports prolonged steady-state choline concentration in plasma. The slow-release transport characteristic helps maintain continuous choline supply for nerve cell and hepatocyte physiological activities, avoiding the fluctuation of effective nutrient concentration caused by rapid metabolism of free choline.

From the perspective of physiological function exertion, sufficient choline supply supports phosphatidylcholine reconstruction for cell membrane repair, and provides precursors for acetylcholine neurotransmitter synthesis. When adopting equal choline dosage, phospholipid‑bound choline can raise tissue choline levels more effectively than free choline supplementation. In practical nutritional application, this means lower effective fortification dosage can reach expected physiological effects. Meanwhile, phospholipid-choline shows milder gastrointestinal tolerance. High-dose free choline supplements are prone to cause stomach upset and fishy body-odor side-effects induced by gut bacterial metabolism, while phospholipid‑bound choline significantly reduces such adverse reactions thanks to its anti-degradation property in intestinal lumen.

It should be noted that both forms of choline can meet human basic nutritional requirements. Free choline salts feature low-cost and high-content advantages for mass fortification. Nevertheless, phospholipid-bound choline stands out for its superior bioavailability, targeted tissue delivery and better tolerance. For brain-health-oriented nutritional products, liver-care formulas and special-population supplementary foods, the natural binding form inside phospholipids offers a high-efficiency choline-supplying solution. As modern nutrition focuses more on actual tissue utilization rather than merely theoretical intake dosage, the absorption superiority of phospholipid-embedded choline has become one core competitive feature of phospholipid‑type nutritional raw materials.